Trials Sponsors Conditions Drugs Pricing

Conditions

Diabetes Complications Gastrointestinal Hemorrhage Multimorbidity

Keywords

multimorbiditymultiple chronic conditionsdrug-drug interactionsdrug-disease interactionspolypharmacyOral anticoagulantsSteroids

Outcome Measures

Primary Outcomes (2)

Patients with gastrointestinal bleeding and anticoagulants or antiplatelet drugs
Do anticoagulants or antiplatelet drugs increase the risk of repeated bleeding in patients with gastrointestinal bleeding?
5 years
Patients with diabetes mellitus and systemic corticosteroids
Do systemic corticosteroids increase the risk of exacerbation in patients with diabetes mellitus?
5 years

Study Arms (1)

Multimorbid patients

Other: drug-drug or drug-disease interaction

Interventions

drug-drug or drug-disease interactionOther

Multimorbid patients

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

We investigate in the field of multimorbidity in a tertiary hospital regarding therapeutic conflicts of GI bleeding and diabetes exacerbation.

You may qualify if:

Inpatients at the University Hospital Zurich, USZ

Sponsors & Collaborators

Center of Competence Multimorbidity, Zurich
Type not reportedcollaborator
University Hospital, Zürich
Othercollaborator
University of Zurich

Study Sites (1)

University Hospital Zurich

Zurich, Switzerland

MeSH Terms

Conditions

Gastrointestinal HemorrhageDiabetes ComplicationsMultiple Chronic Conditions

Interventions

Pharmaceutical Preparations

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsDiabetes MellitusEndocrine System DiseasesChronic DiseaseDisease Attributes

Study Officials

Edouard Battegay, Prof. MD
University Hospital Zurich, Department of Internal Medicine
STUDY DIRECTOR
Klarissa Siebenhüner, MD
University Hospital Zurich, Department of Internal Medicine
PRINCIPAL INVESTIGATOR
Patrick Beeler, MD
University Hospital Zurich, Department of Internal Medicine
STUDY CHAIR

Enrollment

1,101 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 6, 2016

First Posted

October 10, 2016

Study Start

October 2016

Actual (reported)

Therapeutic Conflicts and Multimorbidity

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Study Arms (1)

Multimorbid patients

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Study Arms (1)

Multimorbid patients

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations